Join to View Full Profile
5301 Virginia WaySuite 300Brentwood, TN 37027
Phone+1 615-221-4474
Fax+1 615-234-3774
Dr. Chandra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2007 - 2008
- NYU Grossman School of MedicineFellowship, Hematopathology, 2006 - 2007
- NYU Grossman School of MedicineResidency, Pathology-Anatomic and Clinical, 2002 - 2006
- NYIT College Of Osteopathic MedicineClass of 2001
Certifications & Licensure
- DC State License 2019 - 2027
- MI State License 2021 - 2027
- WV State License 2022 - 2026
- VA State License 2018 - 2026
- MO State License 2013 - 2026
- MD State License 2019 - 2026
- KY State License 2019 - 2026
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsBilineal evolution of a U2AF1-mutated clone associated with acquisition of distinct secondary mutations.Nathan D. Montgomery, Jonathan Galeotti, Steven M Johnson, Leah Commander, Eric T. Weimer
Blood Advances. 2021-09-28 - 3 citationsIn a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.Tauangtham Anekpuritanang, Matthew M. Klairmont, Joel F. Gradowski, Kohei Hagiwara, Nathanael G. Bailey
Blood Advances. 2021-09-24 - 4 citationsCharacterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-a...David L. Saltman, Tyler J. Nielsen, Davide Salina, David R. Hout, Frank McMahon
Therapeutic Advances in Medical Oncology. 2021-04-19
Press Mentions
- Testing for NRG1 Fusions: The New Kid on the Block of Actionable Pathogenic Gene Fusions-March 5, 2025March 4th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: